This is how the Johnson & Johnson vaccine is different from Pfizer and Moderna’s shots

{ object.primary_image.title }}

It only requires one dose and doesn’t need to be kept as cold. The first two COVID vaccines approved in the U.S. both use first-of-a-kind technology called messenger RNA. Johnson & Johnson’s new vaccine is different, and the technology it uses may have helped give it two advantages: It only requires a single dose, and it can be stored for months in a refrigerator instead of an ultra-cold freezer. Read Full Story

More

Moderna’s encouraging vaccine trial: What we know and why the biggest hurdles are still ahead

{ object.primary_image.title }}

The Phase I trail showed encouraging results, but that’s still a long way from a working vaccine that everyone can take. Biotech company Moderna reported positive Phase 1 COVID-19 vaccine trial results this morning, boosting its stock shares by 25% and drumming up a media cyclone of excitement. What does this actually mean, though? Not as much as you hope. Read Full Story

More

Subscribe to our newsletter

Join our newsletter and never miss out trending marketing news.

HitcountVariables(pk=6133, ajax_url='/api/hit/ajax/', hits='5')